6 December 2023 - As New Zealand’s response to the COVID-19 pandemic has evolved, so has ours. ...
6 December 2023 - PHARMAC is drafting its first Equity Policy which outlines the mahi PHARMAC does, can do, or needs ...
10 November 2023 - It’s been one year since CADTH launched the Post-Market Drug Evaluation (PMDE) Program to provide decision-makers with ...
10 October 2023 - “The internal chaos and siege mentality at PHARMAC is exactly why the next Government needs to ...
8 September 2023 - Surrogate outcome measures have an increasingly important role in cancer medicine research providing evidence to support ...
29 August 2023 - Australia has knocked back an application to subsidise the diabetes drug Mounjaro but the manufacturer still wants ...
29 July 2023 - The New Zealand Breast Cancer Foundation is renewing calls for PHARMAC to fund Keytruda for the ...
8 June 2023 - CADTH, Canada’s drug and health technology agency, announces the creation and inaugural membership of a new ...
14 April 2023 - Overpaying for medicines diverts funds away from other treatments and services. ...
30 March 2023 - PHARMAC released its first Clarity Report, containing the latest information about medicines, vaccines, and related products ...
3 March 2023 - PHARMAC will hear from people affected by rare disorders in its upcoming Rare Disorders Advisory Committee meeting ...
8 February 2023 - A process brought in to streamline decision-making around access to new medicines in NHSScotland during the ...
4 February 2023 - The mission of NICE is to get the best care to patients fast, while ensuring value for ...
12 December 2022 - The measurement and valuation of child health-related quality of life is a rapidly evolving field. ...
2 November 2022 - Advances in the digitisation of health systems and expedited regulatory approvals of innovative treatments have led to ...